BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22461172)

  • 1. Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes.
    Kim KO; Sampson ER; Maynard RD; O'Keefe RJ; Chen D; Drissi H; Rosier RN; Hilton MJ; Zuscik MJ
    J Cell Biochem; 2012 Jun; 113(6):2156-66. PubMed ID: 22461172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation.
    Li TF; Darowish M; Zuscik MJ; Chen D; Schwarz EM; Rosier RN; Drissi H; O'Keefe RJ
    J Bone Miner Res; 2006 Jan; 21(1):4-16. PubMed ID: 16355269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation.
    Ferguson CM; Schwarz EM; Reynolds PR; Puzas JE; Rosier RN; O'Keefe RJ
    Endocrinology; 2000 Dec; 141(12):4728-35. PubMed ID: 11108288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
    Vo BT; Cody B; Cao Y; Khan SA
    Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
    Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
    J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arkadia represses the expression of myoblast differentiation markers through degradation of Ski and the Ski-bound Smad complex in C2C12 myoblasts.
    Yuzawa H; Koinuma D; Maeda S; Yamamoto K; Miyazawa K; Imamura T
    Bone; 2009 Jan; 44(1):53-60. PubMed ID: 18950738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATF-2 cooperates with Smad3 to mediate TGF-beta effects on chondrocyte maturation.
    Ionescu AM; Schwarz EM; Zuscik MJ; Drissi H; Puzas JE; Rosier RN; O'Keefe RJ
    Exp Cell Res; 2003 Aug; 288(1):198-207. PubMed ID: 12878171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J; Serra R
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
    Ferrand N; Atfi A; Prunier C
    Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta stimulates cyclin D1 expression through activation of beta-catenin signaling in chondrocytes.
    Li TF; Chen D; Wu Q; Chen M; Sheu TJ; Schwarz EM; Drissi H; Zuscik M; O'Keefe RJ
    J Biol Chem; 2006 Jul; 281(30):21296-21304. PubMed ID: 16690606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation.
    Prunier C; Pessah M; Ferrand N; Seo SR; Howe P; Atfi A
    J Biol Chem; 2003 Jul; 278(28):26249-57. PubMed ID: 12732634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTHrP expression in chick sternal chondrocytes is regulated by TGF-beta through Smad-mediated signaling.
    Pateder DB; Ferguson CM; Ionescu AM; Schwarz EM; Rosier RN; Puzas JE; O'Keefe RJ
    J Cell Physiol; 2001 Sep; 188(3):343-51. PubMed ID: 11473361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad-Runx interactions during chondrocyte maturation.
    Leboy P; Grasso-Knight G; D'Angelo M; Volk SW; Lian JV; Drissi H; Stein GS; Adams SL
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S15-22. PubMed ID: 11263661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3.
    Kang JS; Alliston T; Delston R; Derynck R
    EMBO J; 2005 Jul; 24(14):2543-55. PubMed ID: 15990875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKI knockdown inhibits human melanoma tumor growth in vivo.
    Chen D; Lin Q; Box N; Roop D; Ishii S; Matsuzaki K; Fan T; Hornyak TJ; Reed JA; Stavnezer E; Timchenko NA; Medrano EE
    Pigment Cell Melanoma Res; 2009 Dec; 22(6):761-72. PubMed ID: 19845874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling.
    Sun Y; Liu X; Eaton EN; Lane WS; Lodish HF; Weinberg RA
    Mol Cell; 1999 Oct; 4(4):499-509. PubMed ID: 10549282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Runx2/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes.
    Drissi MH; Li X; Sheu TJ; Zuscik MJ; Schwarz EM; Puzas JE; Rosier RN; O'Keefe RJ
    J Cell Biochem; 2003 Dec; 90(6):1287-98. PubMed ID: 14635200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
    Zhu Q; Pearson-White S; Luo K
    Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski.
    Takeda M; Mizuide M; Oka M; Watabe T; Inoue H; Suzuki H; Fujita T; Imamura T; Miyazono K; Miyazawa K
    Mol Biol Cell; 2004 Mar; 15(3):963-72. PubMed ID: 14699069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.